Steven Mintz, Director at Serina Therapeutics, Inc. (SER), bought 12,380 shares at $9.44 ($121K) on 2024-05-20, disclosed to the SEC on 2024-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 554 | $5K | 3.9% |
| 2 | $9.42 | 1,240 | $12K | 9.7% |
| 3 | $9.44 | 1,240 | $12K | 9.7% |
| 4 | $9.48 | 195 | $2K | 1.5% |
| 5 | $9.75 | 2,500 | $24K | 20.2% |
| 6 | $10.00 | 6,651 |
| $67K |
| 55.0% |
| Total | $9.76 avg | 12,380 | $121K | 100% |
| Filing → |
| SER | BUY | 2024-06-27 | $71K | — | Filing → |